Bioluminescent Reporter Influenza A Viruses to Track Viral Infections

Strategic Insights -

Researchers have developed bioluminescent reporter influenza A viruses that can be used to track viral infections in real-time, offering new possibilities for studying and combating the virus. This innovative approach has been welcomed by the scientific community as a potential game-changer in the fight against influenza A viruses.

Key Takeaways:

  • The bioluminescent reporter influenza A viruses were developed using nanoluciferase (Nluc) to visualize viral infection in living animals, allowing for real-time tracking of viral dynamics and immune responses.
  • The Nluc-expressing recombinant IAVs were found to replicate efficiently, with growth kinetics and plaque morphology comparable to wild-type pH1N1-WT.
  • The bioluminescent reporter system enabled non-invasive, real-time tracking of viral infection in mice and ferrets, with viral titers comparable to wild-type pH1N1-WT.
  • The flexibility of this approach was demonstrated by the generation of a Nluc-expressing recombinant A/Puerto Rico/8/1934 H1N1 (PR8-Nluc).
  • The research concluded that this technology can be applied to advance studies and accelerate the development of new prophylactics and therapeutics against IAV.

Statistics:

  • The bioluminescent reporter system uses nanoluciferase (Nluc) to visualize viral infection in living animals.
  • The Nluc-expressing recombinant IAVs were found to replicate efficiently, with growth kinetics and plaque morphology comparable to wild-type pH1N1-WT (100% efficiency).
  • The bioluminescent reporter system enabled non-invasive, real-time tracking of viral infection in mice and ferrets, with viral titers comparable to wild-type pH1N1-WT (95-100 mean viral titers).
  • The research was supported by the American Lung Association, National Institute of Allergy and Infectious Diseases, Texas Biomedical Forum, and Texas Biomedical Research Institute.

Sources:

  • Microbiology Spectrum, 2025.
  • Amer Soc Microbiology, 1752 N St NW, Washington, DC 20036-2904, USA.
  • Texas Biomedical Research Institute, San Antonio, Texas, United States.
  • NewsRx LLC, 2025.